BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15702447)

  • 1. [Impact of center characteristics on outcome in ovarian cancer in Germany].
    du Bois A; Rochon J; Lamparter C; Pfisterer J
    Zentralbl Gynakol; 2005 Feb; 127(1):18-30. PubMed ID: 15702447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Quality Assurance Program of the AGO Organkommission OVAR (QS-OVAR): Pattern of Care and Reality in Germany 2001].
    du Bois A; Rochon J; Lamparter C; Pfisterer J
    Zentralbl Gynakol; 2005 Feb; 127(1):9-17. PubMed ID: 15702446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
    Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
    Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer.
    Du Bois A; Rochon J; Lamparter C; Pfisterer J;
    Int J Gynecol Cancer; 2005; 15(2):183-91. PubMed ID: 15823098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
    Wethington SL; Herzog TJ; Seshan VE; Bansal N; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Cancer; 2008 Dec; 113(12):3298-306. PubMed ID: 19006196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
    Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
    Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
    Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
    Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Aletti GD; Dowdy S; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of Ca 125 levels during primary therapy.
    Markmann S; Gerber B; Briese V
    Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
    Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
    BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma.
    Skírnisdóttir I; Sorbe B
    Int J Oncol; 2007 Mar; 30(3):727-34. PubMed ID: 17273775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).
    du Bois A; Reuss A; Pujade-Lauraine E; Harter P; Ray-Coquard I; Pfisterer J
    Cancer; 2009 Mar; 115(6):1234-44. PubMed ID: 19189349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Hoppenau B; du Bois A;
    Gynecol Oncol; 2006 Feb; 100(2):300-7. PubMed ID: 16199079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.